Rapid and sustained clearance of circulating lymphoma cells after chemotherapy plus rituximab: clinical significance of quantitative t(14;18) PCR monitoring in advanced stage follicular lymphoma patients-Reference-Cited by-同舟云学术

Rapid and sustained clearance of circulating lymphoma cells after chemotherapy plus rituximab: clinical significance of quantitative t(14;18) PCR monitoring in advanced stage follicular lymphoma patients

Published:2008-06 Issue:5 Volume:141 Page:631-640
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Hirt Carsten,Schüler Frank,Kiefer Thomas,Schwenke Cornelia,Haas Antje,Niederwieser Dietger,Neser Sabine,Aßmann Michael,Srock Stefanie,Rohrberg Robert,Dachselt Klaus,Leithäuser Malte,Rabkin Charles S.,Herold Michael,Dölken Gottfried

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2008.07101.x/fullpdf

Reference41 articles.

1. High Frequency of t(14;18)-Translocation Breakpoints Outside of Major Breakpoint and Minor Cluster Regions in Follicular Lymphomas

2. High-Dose Therapy With Autologous Bone Marrow Support as Consolidation of Remission in Follicular Lymphoma: Long-Term Clinical and Molecular Follow-Up

3. Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study

4. Characterisation of BCL2-JH rearrangements in follicular lymphoma: PCR detection of 3′ BCL2 breakpoints and evidence of a new cluster

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Monitoring of Lymphomas;Annual Review of Pathology: Mechanisms of Disease;2023-01-24

2. Does MRD have a role in the management of iNHL?;Hematology;2021-12-10

3. Long‐term outcome in patients with follicular lymphoma following high‐dose therapy and autologous stem cell transplantation;European Journal of Haematology;2021-08-03

4. Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studiengruppe Hämatologie und Onkologie and the German Low-Grade Lymphoma Study Group;HemaSphere;2021-06-23

5. Stance of MRD in Non-Hodgkin’s Lymphoma and its upsurge in the novel era of cell-free DNA;Clinical and Translational Oncology;2021-05-15